Guillain-Barre syndrome is the most common polyneuropathy causing major disability and respiratory failure. Respiratory complications are the main cause of death. Improved respiratory care and new treatment strategies such as plasmaphoresis and immunoglobulin have been shown to improve outcome. We studied the course and outcome of 37 patients with Guillain-Barr6 syndrome who were admitted to a rehabilitation and respiratory care facility over a 10-year period. There were 21 males and 16 females with a mean age of 62 + 3 years. Fourteen patients developed respiratory failure requiring endotracheal intubation and mechanical ventilation. The mean duration of mechanical ventilation was 38 ± 10 days. All patients were successfully liberated from the ventilator. However, 83 percent of the patients were moderately to severely disabled at the time of discharge. Thirteen out of 37 (35 percent) developed long-term disability. None of the patients died over the period of follow-up. These results indicate that early recognition and treatment of respiratory complications in Guillain-Barre syndrome could reduce the morbidity and mortality of this condition.
INTRODUCTION
Guillain-Barre syndrome is a polyneuropathy characterized by an acute onset of symmetrical motor weakness with diminished or absent reflexes often associated with sensory and autonomic disturbances and a pathological picture of acute inflammatory demyelination and less commonly axonal damage. It is the most common acute neuropathy in the developed world [1] with an annual incidence that varies from 0.5 to 2.0 per 100,000 worldwide [2] and may be increasing in the urban population above the age of 50 [3] . In the United States, the estimated annual incidence is 3.0 cases per 100,000 population, with a marked increase in risk above age 40, and an estimated death rate of 628 cases per year for the epoch 1985-1990 [4] . Guillain-Barre syndrome is also the most common neuromuscular cause of respiratory failure requiring ventilatory support with respiratory complications [5] . However, in recent series, cardiac arrhythmias are shown to be the leading cause of death in Guillain-Barre syndrome [6] . The improved prognosis in recent years has largely resulted from advances in respiratory intensive care. This study reviews the respiratory outcome of 37 
METHODS
A retrospective study of all patients discharged from Gaylord Hospital with a diagnosis of Guillain-Barre syndrome from 1985-1995 was conducted. Thirty-seven patients fulfilled the diagnostic criteria set forth by the National Institute of Neurological Disorders and Stroke as recently confirmed and expanded by Asbury and Comblath [7] . Briefly, patients had to have progressive motor weakness of more than one limb and be areflexic. The majority of patients had cerebrospinal fluid and electrodiagnostic findings, supporting the clinical diagnosis.
RESULTS
There were 21 males (mean age 58 ± 5 years) and 16 females (mean age 68 ± 3 years). As shown in Table 1 [8] . The need for mechanical ventilation most strongly predicts the length of stay for these patients [9] . While this disease usually causes ascending paralysis and subsequent respiratory failure, uncommonly, pure respiratory or autonomic failure [6, 10, 11] or symptoms of upper airway obstruction [12] can be the presenting manifestation. Approximately 10 to 30 percent of patients with Guillain-Barre syndrome will have respiratory complications [5] with an estimated 14 to 25 percent requiring mechanical ventilation [10] . There are several causes of respiratory failure [5] , including inability to protect the upper airway due to bulbar involvement [13] , hypoventilation from denervation of diaphragm [14] and intercostal muscles and complications such as atelectasis (42 percent) and pneumonia (25 to 40 percent) [15] . It is diaphragmatic muscle weakness due to neural involvement that correlates best with ventilatory failure [5] . The central ventilatory drive response to CO2 has been reported to be decreased and contributing to gas exchange abnormality independent of concomitant respiratory muscle weakness [16] . Interestingly, impairment of joint position and vibration sensation of the extremities in those patients with sensory involvement has been associated with a greater need for ventilatory support [17] . [18] . Nevertheless, these patients should also be monitored closely with measurements of vital capacity, maximum inspiratory pressure and arterial blood gases to detect those requiring endotracheal intubation and mechanical ventilation. While elevated arterial PCO2 is the commonest abnormality detected on the arterial blood gases, along with decreased arterial P02, careful attention should be paid to the alveolar-arterial oxygen gradient, a widening of which can be the earliest sign of a pulmonary embolism from deep venous thrombosis, occurring in up to two percent of patients [15] . Other complications of prolonged immobility include hypostatic pneumonia, frank sepsis often originating from the lungs, the urinary tract or decubitus ulceration [8] . Meticulous and vigorous pulmonary toilet and chest physiotherapy while on the ventilator and after tracheal decannulation should minimize complications such as pneumonia and atelectasis. While the trachea can be intubated for up to three weeks, beyond this the incidence of laryngeal and tracheal complications rise sharply. Early tracheostomy in these patients will improve pulmonary toilet, facilitate communication and allow the patient to eat in the absence of bulbar involvement and swallowing dysfunction. In keeping with the protracted course of Guillain-Barre syndrome, the duration of mechanical ventilation is usually prolonged, between 8 to 12 weeks in some series and up to 120 days in our study. Longer durations of ventilation are distinctly unusual [19] . Case reports exist of patients requiring prolonged ventilation, even up to seven years [20] [21] [22] [23] [24] [25] . A few patients are reported to have been liberated from ventilatory support up to 18 months after the initial illness [20] . The standard criteria for weaning from mechanical ventilation are also applicable to GuillainBarre syndrome patients, though the vital capacity and the maximum inspiratory and transdiaphragmatic pressures have been separately favored by different groups as predictors of successful extubation [5, 26, 27] . In the series reporting the longest periods of ventilatory support, no patient could be weaned until the vital capacity improved to greater than one liter [20] . More Cardiac complications are frequent, especially arrhythmias and cardiac arrest in the setting of dysautonomia, with numerous reports of death from the use of succinylcholine for endotracheal intubation [5] . Furthermore, spectral analysis of heart rate and blood pressure variation in mechanically ventilated patients with Guillain-Barre syndrome has revealed a pattern of prominent broad respiratory heart rate variation peaks and narrow blood pressure variation peaks to predict sinus arrest [28] .
Treatment
Plasmapheresis has been shown to reduce the duration of paralysis as well as reduce the duration of mechanical ventilation by 50 percent [29, 30] , with the optimum number of plasma exchanges being shown to vary from two to four based on the severity of the disease [31] . More recently, intravenous immunoglobulin therapy has been shown to be equally efficacious [32, 33] , with a study comparing the addition of methylprednisolone being under way [33] . Steroids alone are of no benefit [34] . To be effective, all treatments need to be started within two weeks of illness or relapse.
Prognosis
The impact of respiratory failure on the disease outcome is profound. In one study [9] , patients requiring ventilatory support had lower Functional Independence Measure Rasch converted scores on presentation, gained less on these scores on discharge and had more than three times the acute length of stay than patients not requiring such support. There are anecdotal reports of impaired ventilatory capacity [35] , or sleep apnea [20] , occurring remote from apparent recovery from Guillain-Barre syndrome. The relapses do occur after a long asymptomatic interval, but they are uncommon [36] . Recovery is the rule in 80 percent of patients [2] , with mortality rates varying from 3 to 18 percent overall [6] and as high as 15 to 30 percent in patients requiring mechanical ventilation [6, 15, 21] . The largest multi-center prospective trial to date, enrolling 297 patients, revealed that patients with preceding Campylobacter infection and those with the axonal degeneration had a shorter time to peak of weakness, a prolonged peak phase, and a worse outcome with a high likelihood of residual muscle weakness. Older patients also fared worse [37] . SUMMARY Guillain-Barre syndrome is the most common cause of respiratory failure and chronic disability due to neuromuscular disorders. Development of respiratory failure correlates directly with high morbidity and mortality as a result of this neuropathy. Early recognition and optimal respiratory care should minimize mortality from this neuropathy.
